Can AI train therapists to treat PTSD? a new study tests Web-Based learning

NCT ID NCT07707102

First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time

Summary

This study compares different ways to train mental health providers in Written Exposure Therapy (WET), an effective treatment for PTSD. Some providers attend a live workshop via video, while others use a self-paced web-based program or an AI-powered training tool called TherapyTrainer. The goal is to see which method helps providers gain the most skill and deliver therapy to more patients, especially veterans. The findings could make PTSD training cheaper and more convenient, expanding access to care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
AI-enhanced web-based training and live workshop training for Written Exposure Therapy
What this could lead to
If successful, this could make evidence-based PTSD treatment training more accessible and affordable, helping more providers deliver effective therapy to veterans and others.
What could go wrong
This is an early-stage study focused on training methods, not patient outcomes. The AI tool may not improve competency as much as live training, and results may vary by provider.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PTSD - POST TRAUMATIC STRESS DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Texas Health Science Center at San Antonio

    San Antonio, Texas, 78229, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.